Skip to main content
Satheesh Chonat, MD, Pediatric Hematology & Oncology, Atlanta, GA, Children's Healthcare of Atlanta

SatheeshChonatMD

Pediatric Hematology & Oncology Atlanta, GA

Associate Professor, Department of Pediatrics, Emory University and Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta

Dr. Chonat is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Chonat's full profile

Already have an account?

Education & Training

  • Cincinnati Children's Hospital Medical Center
    Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Hematology/Oncology, 2012 - 2015
  • Sparrow Hospital
    Sparrow HospitalResidency, Pediatrics, 2009 - 2012
  • Cambridge University Hospitals and London School of Paediatrics
    Cambridge University Hospitals and London School of PaediatricsSpeciality Training Registrar, General Pediatrics, Neonatology and Hematology/Oncology, 2003 - 2009
  • M.S. Ramaiah Medical College
    M.S. Ramaiah Medical CollegeClass of 2003

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2015 - 2025
  • OH State Medical License
    OH State Medical License 2012 - 2017
  • MI State Medical License
    MI State Medical License 2009 - 2012
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Characterization of the Severe Phenotype of Pyruvate Kinase Deficiency
    Satheesh Chonat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Pyruvate Kinase (PK) Protein and Enzyme Levels in the Diagnosis and Clinical Phenotype of PK Deficiency
    Satheesh Chonat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Congenital Dyserythropoietic Anemia Type I Due to Biallelic CDAN1 mutations: Report from the Congenital Dyserythropoietic Anemia Registry (CDAR)
    Satheesh Chonat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Press Mentions

  • Rezurock Approved for Chronic Graft-vs-Host Disease
    Rezurock Approved for Chronic Graft-vs-Host DiseaseAugust 4th, 2021
  • Ultomiris Approved for Pediatric Patients with Paroxysmal Nocturnal Hemoglobinuria
    Ultomiris Approved for Pediatric Patients with Paroxysmal Nocturnal HemoglobinuriaJune 8th, 2021
  • Alexion Announces FDA Approval of ULTOMIRIS® (Ravulizumab-Cwvz) for Children and Adolescents with Paroxysmal Nocturnal Hemoglobinuria (PNH)
    Alexion Announces FDA Approval of ULTOMIRIS® (Ravulizumab-Cwvz) for Children and Adolescents with Paroxysmal Nocturnal Hemoglobinuria (PNH)June 7th, 2021

Hospital Affiliations